Program News - UNC Lineberger

Patient in a hospital bed holds their caregiver's hand

Race and geography linked to different risks of breast cancer treatment delays

A study led by Katherine Reeder-Hayes, MD, MBA, MS, found that Black patients and patients living in certain regions experience greater delays.

Study identifies molecular differences between primary breast cancer and its metastases

A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.

Lisa M. Carey, MD, ScM, FASCO, Charles M. Perou, PhD, and Aranzazu Fernandez-Martinez, MD, PhD

Immune system B-cells can help predict HER2-positive breast cancer treatment response

Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.

Perou presents AACR Distinguished Lectureship in Breast Cancer Research

Charles Perou, PhD, presented the 2022 AACR Distinguished Lectureship in Breast Cancer Research at the 45th San Antonio Breast Cancer Symposium.

Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

Yara Abdou, MD, lead author of the study, presented findings at the San Antonio Breast Cancer Symposium.

UNC Lineberger researchers present findings at San Antonio Breast Cancer Symposium

UNC Lineberger researchers and colleagues will be presenting the latest findings from basic, translational and clinical studies at the 45th annual San Antonio Breast Cancer Symposium.

Exteriors of the UNC Lineberger and Marsico Hall buildings

UNC Lineberger faculty recognized as world’s most highly cited researchers

Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.

Person in a hospital bed with an IV drip

Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

Researchers developed three different computer models to predict how a hypothetical set of patients with specific types of metastatic breast cancer would respond to different sequences and types of chemotherapy.

Study finds that accurate diagnostic mammography outcomes vary by racial and ethnic groups

A study by Sarah J. Nyante, PhD, MSPH, and colleagues found that the rate of diagnostic accuracy is highest in non‐Hispanic white women and lowest in Hispanic women.

Charles M. Perou, Melissa Troester, and Heather D. Couture

Scientists train a computer to classify breast cancer tumors

Using technology similar to the type that powers facial recognition on a smartphone, Charles M. Perou, PhD, Melissa Troester, PhD, and Heather D. Couture have trained a computer to analyze breast cancer images and then classify the tumors with high accuracy.

Stephanie Wheeler, PhD, MPH, has published a study that found adherence to breast cancer medications may play a role in the disparity of outcomes between white and black women.

Black women more likely to report not taking breast cancer medication as prescribed

A study led by UNC Lineberger’s Stephanie Wheeler, PhD, found that black women were more likely than white women to report not taking endocrine therapy for breast cancer as prescribed, which could help explain why hormone-receptor positive breast cancer mortality is higher among black women.